0 CHECKOUT

Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review

  • ID: 1292310
  • March 2016
  • 58 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Alpex Pharma SA
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • Mymetics Corporation
  • Novartis AG
  • MORE

Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alpex Pharma SA
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • Mymetics Corporation
  • Novartis AG
  • MORE

List of Tables

List of Figures

Section 1 - About the Company

Actelion Ltd - Key Facts

Actelion Ltd - Key Employees

Actelion Ltd - Key Employee Biographies

Actelion Ltd - Major Products and Services

Actelion Ltd - Pharmaceutical Pipeline Products Data

Actelion Ltd, Pipeline Products by Therapy Area

Actelion Ltd, Pipeline Products by Development Phase

Actelion Ltd - History

Actelion Ltd - Company Statement

Actelion Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Actelion Ltd - Business Description

Actelion Ltd - Corporate Strategy

Actelion Ltd - SWOT Analysis

SWOT Analysis - Overview

Actelion Ltd - Strengths

Strength - Focused R&D Activities

Strength - Portfolio of PAH Products

Strength - Cost Control

Actelion Ltd - Weaknesses

Weakness - Legal Proceedings

Weakness - Loss of Exclusivity: Tracleer

Actelion Ltd - Opportunities

Opportunity - Products Pipeline

Opportunity - Market Potential: PAH

Opportunity - New Developments

Actelion Ltd - Threats

Threat - Influx of Generics

Threat - Uncertain R&D Outcomes

Threat - Stringent Government Regulations

Actelion Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Actelion Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Sep 10, 2015: ZS Pharma Corporate Statement

Jul 21, 2015: Actelion Delivers Excellent First Half 2015 Results

Jun 26, 2015: Actelion Creates Vaxxilon Together With The Max Planck Society

Apr 21, 2015: Actelion delivers excellent results in the first quarter 2015

Apr 16, 2015: Actelion Advances Clinical Development Of Its Specialty Immunology Pipeline Compounds

Feb 16, 2015: Actelion delivers outstanding 2014 results

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Actelion Ltd, Key Facts

Actelion Ltd, Key Employees

Actelion Ltd, Key Employee Biographies

Actelion Ltd, Major Products and Services

Actelion Ltd, Number of Pipeline Products by Therapy Area

Actelion Ltd, Number of Pipeline Products by Development Stage

Actelion Ltd, Pipeline Products By Therapy Area and Development Phase

Actelion Ltd, History

Actelion Ltd, Subsidiaries

Actelion Ltd, Joint Venture

Actelion Ltd, Key Competitors

Actelion Ltd, Ratios based on current share price

Actelion Ltd, Annual Ratios

Actelion Ltd, Interim Ratios

Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Actelion Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Actelion Ltd, Pipeline Products by Therapy Area

Actelion Ltd, Pipeline Products by Development Phase

Actelion Ltd, Performance Chart (2011 - 2015)

Actelion Ltd, Ratio Charts

Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Actelion Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Note: Product cover images may vary from those shown
3 of 4

Anavex Life Sciences Corp.
Merck Serono S.A.
Novartis AG
Alpex Pharma SA
Santhera Pharmaceuticals Holding AG
Mymetics Corporation
F. Hoffmann-La Roche Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.